- Lupin selects HPE to enhance cloud infrastructure and optimize costs.
- Benefits include improved operational efficiency, data security, and faster innovation.
- HPE Private Cloud Enterprise aims to align with Lupin's growth and quality objectives.
Global pharmaceutical giant Lupin Limited has partnered with Hewlett Packard Enterprise (HPE, Financial) to overhaul its private cloud infrastructure through the HPE Private Cloud Enterprise solution. This move is designed to enhance Lupin's innovation capabilities while optimizing cloud-related costs. As an existing customer of HPE GreenLake, Lupin is set to benefit from a fully managed, turnkey solution that ensures data sovereignty, operational efficiency, and energy savings.
By choosing HPE's solution, Lupin aims to facilitate workload repatriation from the public cloud, thus reducing IT expenditures without sacrificing cloud experiences. The integration will bring real-time monitoring and analytics through edge applications at manufacturing sites, further enhancing quality control and production efficiency.
According to Ramesh Swaminathan, Lupin’s Executive Director, Global CFO & Head of API Plus SBU, the alignment with HPE's private cloud solution is a strategic step towards achieving better flexibility, security, and efficiency, supporting the company's growth and product quality commitment.
Hewlett Packard Enterprise (HPE, Financial) continues to cement its position as a leader in hybrid and private cloud solutions. Som Satsangi, SVP and Managing Director, HPE India, emphasized the collaboration as a testament to HPE’s dedication to providing cutting-edge cloud solutions that drive business success in sectors like pharmaceuticals.
This initiative is expected to bring several key benefits to Lupin, including:
- Enhanced Operational Efficiency: Streamlining operations and reducing downtime by hosting core and edge applications appropriately.
- Improved Data Sovereignty and Security: Secure on-premises cloud deployment ensuring compliance with regulatory standards.
- Faster Innovation Cycles: Enables quicker market launches with scalable and flexible infrastructure.
- Cost Optimization: Centralizing and optimizing workloads with a cost structure aligned to usage, reducing overall operational costs and carbon footprint.
This collaboration is a significant move in Lupin's strategy to innovate rapidly and efficiently within the pharmaceutical industry, ensuring the delivery of consistent, high-quality products to its global customer base.
